Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Sales | 72,646 | 64,174 | 60,396 | 44,853 | 25,006 |
| Cost of Goods | 14,063 | 9,593 | 17,188 | 5,225 | 4,460 |
| Gross Profit | 58,583 | 54,581 | 43,208 | 39,628 | 20,546 |
| Operating Expenses | 56,295 | 50,644 | 42,578 | 49,796 | 38,315 |
| Operating Income | 2,351 | 4,530 | 818 | -9,943 | -17,309 |
| Interest Expense | 4,105 | 4,081 | 4,110 | 4,079 | 4,109 |
| Other Income | 2,835 | 3,514 | 5,116 | 16,749 | 16,394 |
| Pre-tax Income | 1,081 | 3,963 | 1,824 | 2,727 | -5,024 |
| Income Tax | 252 | 153 | 138 | 157 | 192 |
| Net Income Continuous | 829 | 3,810 | 1,686 | 2,570 | -5,216 |
| Net Income | $829 | $3,810 | $1,686 | $2,570 | $-5,216 |
| EPS Basic Total Ops | 0.01 | 0.04 | 0.02 | 0.03 | -0.05 |
| EPS Basic Continuous Ops | 0.01 | 0.04 | 0.02 | 0.03 | -0.05 |
| EPS Diluted Total Ops | 0.01 | 0.04 | 0.02 | 0.03 | -0.05 |
| EPS Diluted Continuous Ops | 0.01 | 0.04 | 0.02 | 0.03 | -0.05 |
| EBITDA(a) | $5,718 | $7,537 | $1,849 | $-9,675 | $-17,357 |